Все категории
| Product Name | Описание | Action |
|---|---|---|
| Дулаглютид, Трулицит, Агонист рецептора ГЛП - 1, LY2189265, Агонист рецептора ГЛП - 1, Фузионный белок Fc / Рекомбинантный синтезный белок, CAS No 923950-08-7 | Trade Name : Trulicity Target : GLP-1 Molecular Type : Fusion Protein Sales in 2025 (Millions of USD) : 2190(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Атезолизумаб, Tecentriq, PD- L1, MPDL3280A, Ингибитор иммунного контрольного пункта Anti- PD- L1, Твердый биологический опухоль, Моноклональные антитела, CAS No 1380723-44-3 | Trade Name : Tecentriq Target : PD-L1 Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 2620(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us... |
|
| Даратумумаб, Дарзалекс, HuMax- CD38, Анти- CD38 моноклональные антитела, Гематологическая- онкологическая биология, Моноклональные антитела, CAS No 945721-28-8 | Trade Name : Darzalex Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 1045(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Секукинумаб | Trade Name : Cosentyx Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 3163(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Омализумаб | Trade Name : Xolair Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 4100(2024/7/1~2025/7/1) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Устекинумаб, Стелара, Интерлейкин-12 Интерлейкин-23, CNTO 1275, Интерлейкиновый ингибитор, Иммунологический биологический, Полностью человеческий моноклональный антитело, CAS No 815610-63-0 | Trade Name : Stelara Target : Interleukin-12 Interleukin-23 Molecular Type : Fully Human Monoclonal Antibody Sales in 2025 (Millions of USD) : 5400(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, ... |
|
| Ритуксимаб, Ритуксан, МабТера, IDEC- C2B8, Анти- CD20 моноклональное антитело, Химерное IgG1 антитело, Моноклональное антитело, CAS No 174722-31-7 | Trade Name : Rituxan Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 520 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Адалимумаб, Хумира, TNF-α, D2E7, LU 200134, Анти- TNF биологический / TNF ингибитор, полностью человеческий моноклональный антитело, аутоиммунный терапевтический / ревматологический биологический, CAS No 331731-18-1 | Trade Name : Humira Target : TNF-α Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 1410 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
